Brainstorm Cell Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $12k | 46k | 0.26 |
| 2021-09-30 | $14k | 4.3k | 3.28 |
| 2021-06-30 | $31k | 8.0k | 3.88 |
| 2021-03-31 | $98k | 26k | 3.84 |
| 2020-12-31 | $39k | 8.7k | 4.49 |
| 2020-09-30 | $221k | 13k | 16.90 |
| 2020-06-30 | $164k | 15k | 11.18 |
| 2019-12-31 | $0 | 3 | 0.00 |
| 2018-03-31 | $0 | 1 | 0.00 |